Reported May 21, 2025 · Ongoing
La Roche-Posay Laboratoire Dermatologique Effaclar Dermatological Acne System, 3 Step Acne Routine Kit, Medicated Gel…
L'Oreal USA
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: L'Oreal USA · 222 Terminal Ave · Clark, NJ · 07066-1317
Is this the product you have?
- La Roche-Posay Laboratoire Dermatologique Effaclar Dermatological Acne System, 3 Step Acne Routine Kit, Medicated Gel Cleanser 3.4 fl. oz. (100 mL) Tube, Clarifying Solution 3.4 fl. oz. (100 mL) Tube, Dual Action Acne Treatment 0.7 fl. oz. (20
- mLUPC 883140035275) Tube, (benzoyl peroxide 0.5% and benzoyl peroxide 5.5% and salicylic acid 2%), La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, France, UPC 883140035282 (kit)
- Lot codes and dates
- Lot #s
- Expiration Dates
MYX30WExp 03/31/2025 MYX32WExp 03/31/2025 MYX33WExp 03/31/2025 MYX41WExp 04/30/2025 MYX42WExp 04/30/2025 MYX43WExp 04/30/2025 MYX44WExp 04/30/2025 MYX45WExp 04/30/2025 MYX50WExp 05/31/2025 MYX51WExp 04/30/2025 MYX52WExp 04/30/2025 MYX53WExp 05/31/2025 MYX70WExp 07/31/2025 MYX80WExp 07/31/2025 MYX81WExp 07/31/2025 MYX90WExp 08/31/2025 MYX91WExp 08/31/2025 MYX92WExp 08/31/2025 MYX93WExp 08/31/2025 MYXD0WExp 09/30/2025 MYXO1WExp 09/30/2025 MYXO2WExp 09/30/2025 MYXO3WExp 09/30/2025 MYXO4WExp 09/30/2025 MYXO5WExp 09/30/2025 MYY21WExp 02/28/2026 MYY23WExp 02/28/2026 MYY26WExp 02/28/2026 MYY27WExp 02/28/2026 MYY31WExp 03/31/2026 MYY32WExp 11/30/2025 MYY33WExp 11/30/2025 MYY34WExp 03/31/2026 MYY50WExp 05/31/2026 MYY51WExp 05/31/2026 MYY60WExp 05/31/2026 MYY61WExp 03/31/2026 MYY62WExp 06/30/2026 MYY63WExp 06/30/2026 MYY64WExp 06/30/2026 MYY72WExp 06/30/2026 MYY73WExp 06/30/2026 MYY74WExp 06/30/2026 MYY75WExp 06/30/2026 MYY76WExp 06/30/2026
- Amount recalled
- 14,460 bottles
This recall covers 3 products
The agency filed one notice per product. You are reading one of them; the other 2 are below.
Where it was sold
- Nationwide
Why it was recalled
cGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new L'Oreal USA recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.